Bids are higher than the last sell - so it's coming up.Haven't read the half yearly as I'm on the wireless connection.Is there any heart starting news in there?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%